[i] Shah, A., Hayes, C. J., and Martin, B., ‘Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use – United States, 2006-2015’, Weekly, March 17 2017. Accessed March 2019: https://www.cdc.gov/mmwr/volumes/66/wr/mm6610a1.htm#F1_down
[ii] The Society of Hospital Pharmacists of Australia, ‘Reducing opioid-related harm: a hospital pharmacy landscape paper’, Nov 2018. Accessed March 2019: https://www.shpa.org.au/sites/default/files/uploaded-content/website-content/shpa_-_reducing_opioid_related_harm.pdf
[iii] Health Quality & Safety Commission. Atlas of healthcare variation. Opioids. 2016. http://www.hqsc.govt.nz/our-programmes/health-quality-evaluation/projects/atlas-of-healthcare-variation/opioids (accessed 16/02/2018
[iv] Australian Bureau of Statistics, ‘3303.0 – Causes of Death, Australia, 2016’. Accessed 4 July 2016 http://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/3303.0~2016~Main%20Features~Drug%20Induced%20Deaths%20in%20Australia~6.